Application of a human mesoderm tissue elongation system in vitro derived from human induced pluripotent stem cells to risk assessment for teratogenic chemicals

Chemosphere. 2020 Jul;250:126124. doi: 10.1016/j.chemosphere.2020.126124. Epub 2020 Feb 7.


Toxic compounds from the mother's diet and medication in addition to genetic factors and infection during pregnancy remain risks for various congenital disorders and misbirth. To ensure the safety of food and drugs for pregnant women, establishment of an in vitro system that morphologically resembles human tissues has been long desired. In this study, we focused on dorsal mesoderm elongation, one of the critical early development events for trunk formation, and we established in vitro autonomous elongating tissues from human induced pluripotent stem cells (hiPSCs). This artificial tissue elongation is regulated by MYOSIN II and FGF signaling, and is diminished by methylmercury or retinoic acid (RA), similar to in vivo human developmental disabilities. Moreover, our method for differentiation of hiPSCs requires only a short culture period, and the elongation is cell number-independent. Therefore, our in vitro human tissue elongation system is a potential tool for risk assessment assays for identification of teratogenic chemicals via human tissue morphogenesis.

Keywords: Dysmorphic disorders; Human pluripotent stem cells; Risk assessment assay; Three-dimensional tissue elongation; Transplacental teratogen.

MeSH terms

  • Cell Differentiation
  • Humans
  • Induced Pluripotent Stem Cells
  • Mesoderm
  • Morphogenesis
  • Risk Assessment
  • Teratogens / toxicity*
  • Toxicity Tests / methods*
  • Tretinoin


  • Teratogens
  • Tretinoin